Literature DB >> 18056246

Physiology of schizophrenia, bipolar disorder, and schizoaffective disorder.

Laura F Martin1, Mei-Hua Hall, Randal G Ross, Gary Zerbe, Robert Freedman, Ann Olincy.   

Abstract

OBJECTIVE: Endophenotypes have been proposed to identify the genetic and biological substrates of complex disorders. Three physiological inhibitory endophenotypes of large effect size in schizophrenia include suppression of P50 auditory evoked responses, inhibition of leading (small anticipatory) saccades during smooth pursuit eye movements, and cancellation of reflexive saccades in the antisaccade eye movement task. The aim of this study was to determine if the pattern of endophenotype abnormalities within individuals with schizophrenia differed from that within individuals with bipolar disorder. A second aim was to determine whether subjects with schizoaffective disorder, bipolar type, were neurophysiologically more similar to subjects with schizophrenia or subjects with bipolar disorder.
METHOD: Endophenotypes were recorded for subjects diagnosed with schizophrenia (N=29), bipolar disorder (DSM-IV-TR) (N=40), and schizoaffective disorder, bipolar type (N=18). Data from normal comparison subjects were used to establish normal performance.
RESULTS: Logistic regression determined that P50 ratio and frequency of leading saccades identified subjects with schizophrenia and bipolar disorder with a sensitivity of 95% and a specificity of 83%. The schizoaffective disorder group was split, with six subjects physiologically classified as schizophrenia-like and 12 subjects as bipolar-like. Those classified as schizophrenia-like were significantly younger at illness onset and had higher symptom ratings.
CONCLUSION: A composite endophenotype of P50 ratio and frequency of leading saccades is consistent with the current clinical nosology of schizophrenia and bipolar disorder and parses patients with schizoaffective disorder, bipolar type, into two subgroups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056246     DOI: 10.1176/appi.ajp.2007.06010017

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  23 in total

Review 1.  Schizoaffective disorder: a review of current research themes and pharmacological management.

Authors:  Joshua T Kantrowitz; Leslie Citrome
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

Review 2.  Future classification of psychotic disorders.

Authors:  Wolfgang Gaebel; Jürgen Zielasek
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

3.  Genetic contribution to individual variation in binocular rivalry rate.

Authors:  Steven M Miller; Narelle K Hansell; Trung T Ngo; Guang B Liu; John D Pettigrew; Nicholas G Martin; Margaret J Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-21       Impact factor: 11.205

4.  Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit.

Authors:  Lauren E Ethridge; Melanie Soilleux; Paul A Nakonezny; James L Reilly; S Kristian Hill; Richard S E Keefe; Elliot S Gershon; Godfrey D Pearlson; Carol A Tamminga; Matcheri S Keshavan; John A Sweeney
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

Review 5.  Endophenotypes in Schizophrenia for the Perinatal Period: Criteria for Validation.

Authors:  Randal G Ross; Robert Freedman
Journal:  Schizophr Bull       Date:  2015-05-04       Impact factor: 9.306

Review 6.  The tell-tale tasks: a review of saccadic research in psychiatric patient populations.

Authors:  Diane C Gooding; Michele A Basso
Journal:  Brain Cogn       Date:  2008-10-23       Impact factor: 2.310

7.  Visual sensory processing deficits in patients with bipolar disorder revealed through high-density electrical mapping.

Authors:  Sherlyn Yeap; Simon P Kelly; Richard B Reilly; Jogin H Thakore; John J Foxe
Journal:  J Psychiatry Neurosci       Date:  2009-11       Impact factor: 6.186

Review 8.  Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia.

Authors:  Randal G Ross; Karen E Stevens; William R Proctor; Sherry Leonard; Michael A Kisley; Sharon K Hunter; Robert Freedman; Catherine E Adams
Journal:  J Child Psychol Psychiatry       Date:  2009-11-18       Impact factor: 8.982

Review 9.  Toward defining schizophrenia as a more useful clinical concept.

Authors:  Jess G Fiedorowicz; Eric A Epping; Michael Flaum
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

Review 10.  Markers of vulnerability in schizophrenia.

Authors:  Maria Ladea; Dan Prelipceanu
Journal:  J Med Life       Date:  2009 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.